NeoGenomics Inc. Common Stock vs Omega Healthcare Investors Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while Omega Healthcare Investors Inc. Common Stock trades at $45 (market cap $13.70B). The key difference: Omega Healthcare Investors Inc. Common Stock is far larger — about 6.4× NeoGenomics Inc. Common Stock's market cap, and Omega Healthcare Investors Inc. Common Stock pays a 6.02% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Omega Healthcare Investors Inc. Common Stock for 0 Days on average.
| NEO | OHI | |
|---|---|---|
Market Cap | $2.14B | $13.70B |
Volume | 2,228,400 | 1,169,953 |
Sector | Health | Real Estate |
52-Week High | $19.91 | $51.72 |
52-Week Low | $7.19 | $39.53 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $17.69B |
Dividend Yield | — | 6.02% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Omega Healthcare Investors Inc. is a real estate investment trust that owns skilled nursing and assisted living facilities, which it leases to healthcare operators under long-term, primarily triple-net lease structures. It partners with healthcare providers across US and UK markets.
Read more on OHI →